- Home
- CRSR vs GHRS Comparison
CRSR vs GHRS Comparison
Compare CRSR & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRSR | GHRS |
|---|---|---|
| Founded | 1994 | 2018 |
| Country | United States | Ireland |
| Employees | 2567 | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 693.8M | 892.0M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRSR | GHRS |
|---|---|---|
| Price | $6.24 | $13.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | $9.94 | ★ $30.11 |
| AVG Volume (30 Days) | ★ 1.1M | 237.1K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,449,248,000.00 | N/A |
| Revenue This Year | $12.96 | N/A |
| Revenue Next Year | $9.28 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.79 | N/A |
| 52 Week Low | $5.35 | $6.72 |
| 52 Week High | $13.02 | $20.50 |
Technical Indicators
Market Signals| Indicator | CRSR | GHRS |
|---|---|---|
| Relative Strength Index (RSI) | 42.45 | 41.50 |
| Support Level | $6.47 | $13.94 |
| Resistance Level | $6.94 | $15.00 |
| Average True Range (ATR) | 0.31 | 0.84 |
| MACD | 0.09 | -0.15 |
| Stochastic Oscillator | 48.92 | 3.99 |
Price Performance
Historical ComparisonAbout CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.